Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 9.26p
   
  • Change Today:
      0.000p
  • 52 Week High: 40.00
  • 52 Week Low: 8.56
  • Currency: UK Pounds
  • Shares Issued: 303.83m
  • Volume: 87,255
  • Market Cap: £28.13m
  • RiskGrade: 479
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
94.74% above the market average94.74% above the market average94.74% above the market average94.74% above the market average94.74% above the market average
93.33% above the sector average93.33% above the sector average93.33% above the sector average93.33% above the sector average93.33% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
4.79% below the market average4.79% below the market average4.79% below the market average4.79% below the market average4.79% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average
Price Book Ratio
63.35% below the market average63.35% below the market average63.35% below the market average63.35% below the market average63.35% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
13.56% below the market average13.56% below the market average13.56% below the market average13.56% below the market average13.56% below the market average
23.4% below the sector average23.4% below the sector average23.4% below the sector average23.4% below the sector average23.4% below the sector average
Price Chg 3m
88.06% below the market average88.06% below the market average88.06% below the market average88.06% below the market average88.06% below the market average
74.47% below the sector average74.47% below the sector average74.47% below the sector average74.47% below the sector average74.47% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
35.37% below the market average35.37% below the market average35.37% below the market average35.37% below the market average35.37% below the market average
20.93% below the sector average20.93% below the sector average20.93% below the sector average20.93% below the sector average20.93% below the sector average
Momentum 20
68.77% below the market average68.77% below the market average68.77% below the market average68.77% below the market average68.77% below the market average
53.49% below the sector average53.49% below the sector average53.49% below the sector average53.49% below the sector average53.49% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
1.33% above the market average1.33% above the market average1.33% above the market average1.33% above the market average1.33% above the market average
52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
17.34% below the market average17.34% below the market average17.34% below the market average17.34% below the market average17.34% below the market average
53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average
Forecast EPS
90.76% below the market average90.76% below the market average90.76% below the market average90.76% below the market average90.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
34.99% below the market average34.99% below the market average34.99% below the market average34.99% below the market average34.99% below the market average
5.88% above the sector average5.88% above the sector average5.88% above the sector average5.88% above the sector average5.88% above the sector average
Operating Profit Loss
6.97% below the market average6.97% below the market average6.97% below the market average6.97% below the market average6.97% below the market average
57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
32.77% below the market average32.77% below the market average32.77% below the market average32.77% below the market average32.77% below the market average
13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average
Cash
6.78% below the market average6.78% below the market average6.78% below the market average6.78% below the market average6.78% below the market average
17.39% above the sector average17.39% above the sector average17.39% above the sector average17.39% above the sector average17.39% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
27.66% below the market average27.66% below the market average27.66% below the market average27.66% below the market average27.66% below the market average
45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average
Buys 1y
20.58% above the market average20.58% above the market average20.58% above the market average20.58% above the market average20.58% above the market average
7.14% below the sector average7.14% below the sector average7.14% below the sector average7.14% below the sector average7.14% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
65.15% above the market average65.15% above the market average65.15% above the market average65.15% above the market average65.15% above the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 9.26p
Change Today 0.000p
% Change 0.00 %
52 Week High 40.00
52 Week Low 8.56
Volume 87,255
Shares Issued 303.83m
Market Cap £28.13m
Beta 0.01
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
36.16% below the market average36.16% below the market average36.16% below the market average36.16% below the market average36.16% below the market average
87.23% above the sector average87.23% above the sector average87.23% above the sector average87.23% above the sector average87.23% above the sector average
Price Trend
94.24% below the market average94.24% below the market average94.24% below the market average94.24% below the market average94.24% below the market average
87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average
Income Not Available
Growth
22.00% above the market average22.00% above the market average22.00% above the market average22.00% above the market average22.00% above the market average
22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 19-May-2025

Time Volume / Share Price
11:18 546 @ 9.15p
09:23 2,298 @ 8.70p
09:23 20,000 @ 9.26p
09:23 20,000 @ 9.26p
09:18 10,576 @ 9.46p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page